Adolescent and young adult (AYA) patients with acute lymphoblastic leukemia (ALL) were significantly more likely to relapse than pediatric ALL patients, and factors including lower clinical trial enrollment and shorter duration of therapy were associated with relapse. The study is published in the Cancer Epidemiology, Biomarkers & Prevention, by Julie A. Wolfson, MD, MSHS, assistant […]